Financials
Financial year 2025
Apotheek Weert from Oud-Heverlee, company number BE0898636110, closed financial year 2025 with a result of € 86,735 after tax. For that financial year Apotheek Weert recorded a gross margin of € 180,285 and equity of € 366,301. Compared with financial year 2024, the result moved from € 85,901 to € 86,735. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 11, 2026.
€ 366,301
▲ 15% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 86,735
▲ 1% vs 2024
Profit after tax over the fiscal year.
€ 258,368
▲ 45% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 40,000 paid out
46 % of the profit went to the shareholders, mostly to Prieels Pharma (100 % of the shares). That is where the money ends up.
People and assets in 2025
0.5
Average over the fiscal year, from the social balance sheet.
€ 42,362
▼ 14% vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2025
€ 165,784
▲ € 161,192 vs 2024
€ 9,518 is repaid this year. At this pace the long-term loan is gone in ≈ 17 years.
€ 148,752
▲ 10% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 11,317
▲ 1% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 178,162 | € 154,808 | € 184,814 | € 180,285 | ▼ 2% |
| Profit after taxes | € 75,676 | € 66,469 | € 85,901 | € 86,735 | ▲ 1% |
| Equity | € 232,195 | € 298,664 | € 319,566 | € 366,301 | ▲ 15% |
| Total debts | € 298,864 | € 248,144 | € 154,080 | € 368,562 | ▲ 139% |
| Cash | € 194,140 | € 261,720 | € 178,290 | € 258,368 | ▲ 45% |
| Land & buildings | € 4,180 | € 2,258 | € 2,573 | € 141,590 | ▲ € 139,017 |
| Retained profit | € 222,195 | € 288,664 | € 299,566 | € 346,301 | ▲ 16% |
| Dividend | € 0 | € 0 | € 75,000 | € 40,000 | ▼ 47% |
| Bank debt | € 40,983 | € 22,864 | € 4,592 | € 165,784 | ▲ € 161,192 |
| Balance sheet total | € 531,060 | € 546,808 | € 473,645 | € 734,863 | ▲ 55% |
| Employees (FTE) | 0.7 | 0.5 | 0.5 | 0.5 |
By gross margin, Apotheek Weert ranks 218th of 435 companies with main activity “Detailhandel in farmaceutische producten” in Flemish Brabant that publish figures (fiscal year 2025).
Key figures of Apotheek Weert, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
Ask about Apotheek Weert the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to Apotheek Weert?
What happened at Apotheek Weert in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 86,735 (▲ 1% vs 2024). Source: NBB ↗
- Prieëls Pharma BV stepped down as director. NBB
- W.D. Partners BV stepped down as director. NBB
- Prieëls Pharma BV became a director. NBB
- W.D. Partners BV became a director. NBB
- New establishment in Oud-Heverlee. KBO
- Incorporation, published in the Gazette. Source: Staatsblad ↗
In short
From € 75,676 profit in 2022 to € 86,735 profit in 2025.
Paid € 95,966 in corporate taxes since 2022.
Best year ever: 2025, with € 86,735 profit.
Paid out € 115,000 in dividends to the owners in total.
Management
The stake of Prieels Pharma, W.D. PARTNERS comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
Apotheek WeertThe shares are held by Prieels Pharma (100%) and W.D. PARTNERS (99.9%).
Directors
According to the 2025 annual accounts
Director · represented by Anne Willekens
since 2025 · until 2025
Director · represented by Gijs Prieëls
since 2025 · until 2025
Shareholders
100%
99.9%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Leuvensestraat 5
3051 Oud-Heverlee
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Similar companies in Flemish Brabant
Same main activity (Detailhandel in farmaceutische producten), 482 active companies in Flemish Brabant, largest first.
€ 1.9 million gross margin · 2025 · Kortenberg
€ 1.5 million gross margin · 2025 · Bertem
€ 1.3 million gross margin · 2025 · Scherpenheuvel-Zichem
€ 1 million gross margin · 2025 · Sint-Pieters-Leeuw
€ 894,811 gross margin · 2025 · Diest
€ 868,621 gross margin · 2025 · Aarschot
Shareholders according to the Official Gazette deeds
Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.
Incorporation
Source: Deed ↗- W.D. PARTNERS(oprichter) 99.9%
- WILLEKENS Anne(oprichter) 0.1%
Details
- Company number
- 0898.636.110
- VAT number
- BE 0898.636.110
- Registered office
- Leuvensestraat 5, 3051 Oud-Heverlee
- Names & denominations
- Apotheek Weert
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 6 June 2008
- Peppol
- Active · Active since 1 Jan 2001
- Activities · NACE
Detailhandel in farmaceutische producten